Tribogenics Receives Strategic Investment from Nikon Americas

Tribo_logoTribogenics, the Los Angeles, Calif.-based inventor of triboluminescence based X-ray technology for industrial, security and scientific applications, received a strategic investment from Nikon Americas Inc., a subsidiary company of Nikon Corporation.

The amount of the deal was not disclosed.

Led by Dale Fox, Chief Executive Officer, Tribogenics is an innovator of triboluminescence based X-ray technology for industrial, medical, and scientific industries.
Its Watson™ XRF hand-held analyzers remove the risk of error in manufacturing QA/QC environments by performing non-destructive testing (NDT) and PMI of metals and alloys. Initially, Watson™ is used in scrap metal recycling, metal fabrication, machining and manufacturing products for use in the aerospace, automotive, medical, military, scientific and industrial sectors.

The company intends to use the funds to accelerate the commercialization of Watson products.

Together, Nikon Group and Tribogenics will will work together to expand the sales channel with handheld XRF analyzers, cabinet-type X-ray and CT products. Both companies will share information on joint technology, business and marketing development programs. Nikon Group will also expand its non-destructive and non-contact testing business.



Join the discussion